IDFC Securities - Healthcare Global Enterprises (HCG) HealthCare Global Enterprises Q3FY20 results (Outperformer) - Capex cycle nears an end Q3FY20 result highlights
Revenues grew by 12% yoy to Rs2.78bn below est of Rs2.86bn with HCG centres posting 12% growth yoy. Milann centres grew 8.6% yoy.
EBITDA stood higher at Rs457m. Adjusting
CCI approves Aceso's acquisition of 58.92% stake in HealthCare Global Enterprises - The Economic Times In a tweet, the Competition Commission of India (CCI) said it "approves acquisition of upto 58.92% stake of HealthCare Global Enterprises Limited by Aceso Company Pte. Ltd."
Deals of the day: BNP Paribas sells stake in RBL Bank; Fidelity offloads shares of SH Kelkar Fidelity Investment Trust's Fidelity Series Emerging Markets Fund sold 8,10,800 shares of SH Kelkar at an average price of Rs 65.24 per share
Trade Setup for Wednesday: Top 15 things to know before Opening Bell Key support level for Nifty is placed at 8,812.82, followed by 8,746.53. If the index moves up, key resistance levels to watch out for are 8,987.87 and 9,096.63.